David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...

The FDA has given approval for the first clinical trials of pig kidney transplants in humans, representing a significant ...

FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.&nb ...

A 66-year-old New Hampshire man received the kidney as part of a small pilot study at Mass General Brigham. United Therapeutics, another developer of gene-edited pig organs, just won FDA approval for ...

A 66-year-old man, Tim Andrews, has successfully undergone a pig kidney transplant, becoming the second person to do so.

Get real-time updates on international politics, economic changes, conflicts, and environmental issues. Access the latest ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...